Provides preventive healthcare solutions in the People's Republic of China. Offers disease screening services to identify health risks early. Now — the numbers.
This is an established company with proven profits.
Average growth of 79% a year over the last 4 years. Red columns mark years that ended in a loss.
If every debt were paid off today, $1.6M would still be left in the vault — a solid cushion for hard times.
The market pays 33.2× for every dollar this company earns in a year — a price that already assumes things go well.
No analyst target is on record for this company.
angles, checked one by one.
The 3 that stand out are on screen; the rest came back neutral.
The council scores out of 10; report-card grades are out of 100.
Trading Liquidity: The shares change hands too rarely for smooth trading.
An investor who bought at the very peak is down 100% today. The business is the same; what changed most is the price — and the expectations — the market pins on it.
Over the last 4 years, sales grew about 79% a year on average.
There is $1.6M in the vault; even if every debt were paid off, $1.6M would remain.
The stock sits at $0.51. Under exchange rules, stocks that stay below $1 for too long risk being removed from the market.
The company’s market value is 33 times its annual profit. Even a small disappointment could hit the price hard.
No score published: this stock trades under $10,000 on a typical day, so the price beside it is not one you could reliably act on.
One-line summary: few numbers, an untested story. Keep watching.
Not covered, because the filings we hold do not carry it: earnings execution, the revenue breakdown.